Armstrong Shaw Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.9M | Hold |
41,518
| – | – | 3.05% | 14 |
|
|
2023
Q2 | $2.87M | Sell |
41,518
-4,601
| -10% | -$327K | 2.92% | 14 |
|
|
2023
Q1 | $3.43M | Sell |
46,119
-2,049
| -4% | -$172K | 3.36% | 10 |
|
|
2022
Q4 | $4.49M | Sell |
48,168
-531
| -1% | -$51.2K | 4.46% | 9 |
|
|
2022
Q3 | $4.64M | Hold |
48,699
| – | – | 4.98% | 7 |
|
|
2022
Q2 | $4.51M | Hold |
48,699
| – | – | 4.55% | 7 |
|
|
2022
Q1 | $4.93M | Hold |
48,699
| – | – | 4.12% | 8 |
|
|
2021
Q4 | $5.02M | Hold |
48,699
| – | – | 4.09% | 8 |
|
|
2021
Q3 | $4.13M | Buy |
48,699
+877
| +2% | +$73.5K | 3.61% | 8 |
|
|
2021
Q2 | $3.99M | Sell |
47,822
-1,411
| -3% | -$116K | 3.47% | 10 |
|
|
2021
Q1 | $3.7M | Sell |
49,233
-396
| -0.8% | -$28.8K | 3.39% | 13 |
|
|
2020
Q4 | $3.39M | Sell |
49,629
-609
| -1% | -$39.6K | 3.32% | 14 |
|
|
2020
Q3 | $2.93M | Sell |
50,238
-11
| -0% | -$684 | 3.47% | 13 |
|
|
2020
Q2 | $3.27M | Sell |
50,249
-4,647
| -8% | -$293K | 3.99% | 8 |
|
|
2020
Q1 | $3.26M | Sell |
54,896
-593
| -1% | -$39.6K | 4.13% | 8 |
|
|
2019
Q4 | $4.12M | Sell |
55,489
-4,945
| -8% | -$347K | 3.62% | 10 |
|
|
2019
Q3 | $3.81M | Hold |
60,434
| – | – | 3.45% | 11 |
|
|
2019
Q2 | $3.29M | Sell |
60,434
-16
| -0% | -$862 | 3.01% | 14 |
|
|
2019
Q1 | $3.26M | Buy |
60,450
+23,275
| +63% | +$1.44M | 3.13% | 15 |
|
|
2018
Q4 | $2.44M | Sell |
37,175
-699
| -2% | -$52.2K | 2.55% | 19 |
|
|
2018
Q3 | $2.98M | Sell |
37,874
-451
| -1% | -$32.2K | 2.56% | 20 |
|
|
2018
Q2 | $2.47M | Buy |
38,325
+2
| +0% | +$132 | 2.24% | 23 |
|
|
2018
Q1 | $2.38M | Sell |
38,323
-587
| -2% | -$42.1K | 2.15% | 25 |
|
|
2017
Q4 | $2.82M | Buy |
38,910
+195
| +0.5% | +$14.2K | 2.38% | 23 |
|
|
2017
Q3 | $3.15M | Sell |
38,715
-54,023
| -58% | -$4.27M | 2.84% | 21 |
|
|
2017
Q2 | $7.46M | Sell |
92,738
-50,823
| -35% | -$4.01M | 2.81% | 20 |
|
|
2017
Q1 | $11.3M | Sell |
143,561
-12,326
| -8% | -$984K | 2.82% | 21 |
|
|
2016
Q4 | $12.3M | Sell |
155,887
-5,654
| -4% | -$457K | 2.93% | 19 |
|
|
2016
Q3 | $14.4M | Buy |
161,541
+615
| +0.4% | +$58.1K | 3.57% | 9 |
|
|
2016
Q2 | $15.4M | Sell |
160,926
-246
| -0.2% | -$24.5K | 3.93% | 4 |
|
|
2016
Q1 | $16.7M | Sell |
161,172
-12,767
| -7% | -$1.24M | 4.32% | 3 |
|
|
2015
Q4 | $17M | Sell |
173,939
-5,605
| -3% | -$549K | 4.01% | 2 |
|
|
2015
Q3 | $17.3M | Sell |
179,544
-45,631
| -20% | -$4.8M | 4.2% | 3 |
|
|
2015
Q2 | $23.6M | Sell |
225,175
-26,358
| -10% | -$2.69M | 5.11% | 1 |
|
|
2015
Q1 | $26M | Sell |
251,533
-42,654
| -14% | -$4.32M | 5.57% | 1 |
|
|
2014
Q4 | $28.3M | Sell |
294,187
-10,154
| -3% | -$895K | 5.13% | 1 |
|
|
2014
Q3 | $24.2M | Sell |
304,341
-8,610
| -3% | -$679K | 4.41% | 1 |
|
|
2014
Q2 | $23.6M | Sell |
312,951
-161,270
| -34% | -$12.2M | 4.26% | 1 |
|
|
2014
Q1 | $35.5M | Sell |
474,221
-1,132,197
| -70% | -$80M | 4.36% | 1 |
|
|
2013
Q4 | $115M | Sell |
1,606,418
-2,848
| -0.2% | -$183K | 4.25% | 1 |
|
|
2013
Q3 | $91.3M | Sell |
1,609,266
-6,140
| -0.4% | -$366K | 3.71% | 2 |
|
|
2013
Q2 | $92.4M | Buy |
+1,615,406
| New | +$93.6M | 3.86% | 1 |
|
Other funds holding CVS
Armstrong Shaw Associates's CVS Position: Q3 2023 in Review
Armstrong Shaw Associates held its CVS Health (CVS) position steady in Q3 2023 at 41,518 shares worth $2.9M. The position accounts for 3.05% of the portfolio, ranked #14.
Armstrong Shaw Associates first reported a position in CVS in Q2 2013 and has held it in 42 quarters since. The position peaked at $115M in Q4 2013. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Armstrong Shaw Associates held 41,518 shares of CVS Health worth $2.9M as of Q3 2023.
- Armstrong Shaw Associates left its CVS Health share count unchanged in Q3 2023.
- CVS Health made up 3.05% of Armstrong Shaw Associates's portfolio in Q3 2023, its #14 holding.
- Armstrong Shaw Associates first reported a position in CVS Health in Q2 2013 and has held it in 42 quarters since.
- Armstrong Shaw Associates's CVS Health position peaked at $115M in Q4 2013.
- 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Armstrong Shaw Associates's 13F filing for Q3 2023, filed 13 Oct 2023.